BMSEED Receives Phase II SBIR Award from NIH

 
 

BMSEED proposed the commercialization of their Micro-Electrode Array Stretching Stimulating und Recording Equipment (MEASSuRE) technology. MEASSuRE bridges the gap between in vitro and in vivo research by simulating the biomechanical and electrical environment of cells in the body in a controlled environment outside of the body. With this technique, MEASSuRE can evaluate hippocampal tissue slices for TBI research, regenerative medicine using cardiomyocytes, and SCI research with tissue slices. Read more about the project here.

Previous
Previous

BMSEED Presenting at 2018 Society for Neuroscience Conference

Next
Next

BMSEED Presenting at 2018 MEA Meeting